首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncoimmunology

缩写:ONCOIMMUNOLOGY

ISSN:2162-402X

e-ISSN:2162-402X

IF/分区:6.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引914
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Meng Li,Di Li,Hai-Yun Wang et al. Meng Li et al.
The exploration of therapeutic targets in neuroblastoma (NB), which needs more attempts, can benefit patients with high-risk NB. Based on metabolomic and transcriptomic data in mediastinal NB tissues, we found that the content of long-chain...
Maria Paula Roberti,Pornpimol Charoentong,Yanhong Lyu et al. Maria Paula Roberti et al.
T cells that recognize tumor-specific mutations are crucial for cancer immunosurveillance and in adoptive transfer of TILs or transgenic-TCR T cell products. However, their challenging identification and isolation limits their use in clinic...
Esen Yonca Bassoy,Remya Raja,Thomas E Rubino Jr et al. Esen Yonca Bassoy et al.
Most high-grade serous ovarian cancers (OC) do not respond to current immunotherapies. To identify potential new actionable tumor antigens in OC, we performed immunopeptidomics on a human OC cell line expressing the HLA-A02:01 haplotype, wh...
Lorenzo Galluzzi,Aitziber Buqué Lorenzo Galluzzi
In an immunocompetent mouse model of multifocal, metachronous HR+ mammary carcinogenesis, we have recently demonstrated that a superior control of primary neoplastic lesions by focal radiotherapy does not necessarily translate into improved...
Syrine Abdeljaoued,Alexandre Doussot,Marie Kroemer et al. Syrine Abdeljaoued et al.
Tissue-resident memory (TRM) T cells have emerged as key players in cancer immunosurveillance, and their presence has been linked to a favorable clinical outcome in solid cancer patients. Liver metastases exhibit a highly immunosuppressive ...
Kengo Tanigawa,William L Redmond Kengo Tanigawa
Immune checkpoint blockade (ICB) has significantly improved the survival for many patients with advanced malignancy. However, fewer than 50% of patients benefit from ICB, highlighting the need for more effective immunotherapy options. High-...
Zuhairah Binte Hanafi,Yu Mei,Huey Yee Teo et al. Zuhairah Binte Hanafi et al.
Tumor-promoting inflammation significantly impacts cancer progression, and targeting inflammatory cytokines has emerged as a promising therapeutic approach in clinical trials. Interleukin (IL)-1α, a member of the IL-1 cytokine family, play...
Miriam Velasco-Sidro,Javier Arroyo-Ródenas,Laura Díez-Alonso et al. Miriam Velasco-Sidro et al.
Despite recent advances in immunotherapy against B cell malignancies such as BCMA (B cell maturation antigen) and CD19-targeted treatments using soluble T cell-engaging (TCE) antibodies or chimeric antigen receptor T cells (CAR-T), there is...
Rui Sun,Kang Yi Lee,Yu Mei et al. Rui Sun et al.
Regulatory T cells (Tregs) contribute significantly to the immunosuppressive nature of the tumor microenvironment which is a main barrier for immunotherapies of solid cancers. Reducing Treg numbers enhances anti-tumor immune responses but c...